235 related articles for article (PubMed ID: 292450)
21. Leukaemia-associated antigen (LAA) in proliferative blood disorders.
Stavem P; Berg K; Noer G
Scand J Haematol; 1977 Jan; 18(1):13-9. PubMed ID: 265091
[TBL] [Abstract][Full Text] [Related]
22. Proliferating cell nuclear antigen in blast crisis cells of patients with chronic myeloid leukemia.
Takasaki Y; Robinson WA; Tan EM
J Natl Cancer Inst; 1984 Sep; 73(3):655-61. PubMed ID: 6147434
[TBL] [Abstract][Full Text] [Related]
23. Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis.
Shumak KH; Baker MA; Taub RN; Coleman MS
Cancer Res; 1980 Nov; 40(11):4048-52. PubMed ID: 6937237
[TBL] [Abstract][Full Text] [Related]
24. Identification and characterization: cell membrane antigens associated with the blast phase of human adult leukemia.
Hollinshead AC; Herberman RB
Bibl Haematol; 1975; (40):339-48. PubMed ID: 1057947
[TBL] [Abstract][Full Text] [Related]
25. Assessment of the mixed leucocyte reaction by target cell death: a study of leukaemic cells.
Pegrum GD; Evans CA; Middleton VL; Balfour IC
Clin Exp Immunol; 1972 Feb; 10(2):251-6. PubMed ID: 4505586
[TBL] [Abstract][Full Text] [Related]
26. The immunological classification of leukaemia based on a rapid microcytotoxicity test.
Billing RJ; Foon KA; Linker-Israeli M
Clin Exp Immunol; 1982 Jul; 49(1):142-8. PubMed ID: 6957278
[TBL] [Abstract][Full Text] [Related]
27. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings.
Khalidi HS; Brynes RK; Medeiros LJ; Chang KL; Slovak ML; Snyder DS; Arber DA
Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654
[TBL] [Abstract][Full Text] [Related]
28. Stimulatory ability of human leukaemic cells in the allogeneic mixed leucocyte reaction.
Ashman LK
Aust J Exp Biol Med Sci; 1983 Aug; 61 (Pt 4)():477-88. PubMed ID: 6228214
[TBL] [Abstract][Full Text] [Related]
29. Antigen solubilized from human leukemia: lymphocyte stimulation.
Gutterman JU; Mavligit G; McCredie KB; Bodey GP; Freireich EJ; Hersh EM
Science; 1972 Sep; 177(4054):1114-5. PubMed ID: 4506296
[TBL] [Abstract][Full Text] [Related]
30. Cell-mediated cytotoxicity as a result of immunotherapy in patients with acute myeloid leukaemia.
Taylor GM; Harris R; Freeman CB
Br J Cancer; 1976 Feb; 33(2):137-43. PubMed ID: 1063029
[TBL] [Abstract][Full Text] [Related]
31. Leukocyte migration studies in chronic myeloid leukemia (CML). Specificity of reactions.
Gothoskar BP; D'Silva H; Gharpure H; Advani SH
Eur J Cancer (1965); 1976 Oct; 12(10):815-21. PubMed ID: 61861
[No Abstract] [Full Text] [Related]
32. Specific xenogenous antiserum to cells of chronic myeloid leukemia (CML) in blastic crisis.
Baryshnikov AJ; Radzikhovskaya RM; Morozova LF; Belyanchikova NI; Slavina EG; Vinogradova JE; Mkheidze DM; Polotskaya TM; Volkova MA; Svet-Moldavsky GJ; Nikitin VD; Kutimov VA; Trubitsina VI; Goletsky SA; Glazunov A
Biomedicine; 1976 Dec; 25(9):316-7. PubMed ID: 1069594
[TBL] [Abstract][Full Text] [Related]
33. Detection of human leukaemia associated antigens in leukaemic serum and normal embryos.
Harris R; Viza D; Todd R; Phillips J; Sugar R; Jennison RF; Marriott G; Gleeson MH
Nature; 1971 Oct; 233(5321):556-7. PubMed ID: 4329823
[No Abstract] [Full Text] [Related]
34. Surface immunoglobulins and protease inhibitors of human acute leukemia blasts.
Cotropia JP; Gutterman JU; Hersh EM; Mavligit GM
Int J Cancer; 1977 Oct; 20(4):520-31. PubMed ID: 410736
[No Abstract] [Full Text] [Related]
35. [Differentiation antigens of malignant leukocytes (2)].
Bernard A; Boumsell L
Presse Med; 1984 Nov; 13(39):2371-4, 2379-80. PubMed ID: 6239204
[TBL] [Abstract][Full Text] [Related]
36. Cell-mediated immune responses between HLA-identical siblings: recognition of antigenic changes associated with acute myelogenous leukaemia.
Zier KS; Huber C; Albert E; Braunsteiner H
Clin Exp Immunol; 1980 Apr; 40(1):136-46. PubMed ID: 6446429
[TBL] [Abstract][Full Text] [Related]
37. Surface antigens on leukaemic myeloid cells. I. Distribution and movement of antigens reacting to antilymphocytic globulins.
Bacigalupo A; Santini G; Piaggio G; Giordano D; Marmont AM
Haematologica; 1977 Apr; 62(2):136-43. PubMed ID: 406171
[No Abstract] [Full Text] [Related]
38. Immunotherapy versus chemotherapy of acute myeloid leukemia: response to PHA, allogeneic lymphocytes, and leukemic myeloblasts of remission lymphocytes from leukemia patients.
Reizenstein P; Ogier C; Sjögren AM
Recent Results Cancer Res; 1980; 75():29-36. PubMed ID: 6940210
[TBL] [Abstract][Full Text] [Related]
39. Distinct T cell populations distinguish chronic myeloid leukaemia cells from lymphocytes in the same individual: a model for separating GVHD from GVL reactions.
Datta AR; Barrett AJ; Jiang YZ; Guimarães A; Mavroudis DA; van Rhee F; Gordon AA; Madrigal A
Bone Marrow Transplant; 1994 Oct; 14(4):517-24. PubMed ID: 7858526
[TBL] [Abstract][Full Text] [Related]
40. Specificities of heterologous antisera against human leukaemia cells. 1. Reactions against leukaemia cells.
Thränhardt H; Milleck J; Zintl F; Koppitz D; Plenert W; Raderecht C; Richter KV
Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(4):463-74. PubMed ID: 83265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
